Records containing: Severe Acute Respiratory Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-20Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-01-05COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
-
CLINICAL_TRIALS study record update · 2022-01-04Ivermectin in Adults With Severe COVID-19. Double-blind Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-10-26Utilização da Enoxaparina em Dose Anticoagulante em Pacientes Hospitalizados Com síndrome respiratória Aguda Grave Por COVID-19
-
CLINICAL_TRIALS study record update · 2021-09-24PRAETORIAN-COVID: A Double-blind, Placebo-controlled Randomized Clinical Trial With Valsartan for PRevention of Acute rEspiraTORy dIstress Syndrome in hospitAlized patieNts With SARS-COV-2 (COVID-19) Infection Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-09-16COVID-19-Related Health and Practices Among Dental Hygienists
-
CLINICAL_TRIALS study record update · 2021-08-20COVID-19 (CoviCompareCV): A Phase 3, Non-randomized, Open Label Clinical Trial to Evaluate the Immunogenicity and Safety of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV Administered Intramuscularly in Adults Aged 65 Years or Above Compared to Younger Adults Aged 18-45 Years
-
CLINICAL_TRIALS study record update · 2021-05-11Communication in ICU During COVID-19: Multinational, Multicentric Cross-sectional Survey (ComICU)
-
CLINICAL_TRIALS study record update · 2021-03-23Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19
-
CLINICAL_TRIALS study record update · 2021-02-09Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2020-11-17Prevalence and Risk Factors of COVID-19 Infection in the Upper Silesian Agglomeration Population in 2020
-
CLINICAL_TRIALS study record update · 2020-10-19Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19
-
CLINICAL_TRIALS study record update · 2020-07-21A Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and in Combination With NA-831 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-06-16Obesity as a Risk Factor for Mortality of Critically Ill Patients With Coronavirus Disease 2019 (COVID-19): a Cohort Study of the First Wave in Nancy, France
-
CLINICAL_TRIALS study record update · 2020-06-02Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria. Identification of Diabetes-related Associated Factors Severe Forms
-
CLINICAL_TRIALS study record update · 2020-05-11Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2018-03-14Streptokinase Versus Unfractionated Heparin Nebulization in Patients With Severe Acute Respiratory Distress Syndrome (ARDS): A Partially Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-07-02Clinical Evaluation and Management of Persons With Severe Acute Respiratory Syndrome (SARS)
-
CLINICAL_TRIALS study record update · 2017-07-02Collection of Convalescent SARS Plasma by Apheresis
-
CLINICAL_TRIALS study record update · 2013-08-22A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
-
CLINICAL_TRIALS study record update · 2013-04-17A Randomized, Dose-ranging Study of Alferon® LDO {Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)} in Normal Volunteers and/or Asymptomatic Subjects With Exposure to a Person Known to Have SARS or Possible SARS
-
CLINICAL_TRIALS study record update · 2012-12-10ClinicalTrials.gov study NCT00172263